Media Summary: Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series. In this keynote from the 2023 CGT Summit hosted by Charles River Laboratories, Dr. Peter Marks, Director of the FDA's Center for ... Advancing RNA Live panelists Venkat Krishnamurthy, April Sena, and Max De Long share their perspectives on the most ...
Recent Cmc Guidance For Cellular - Detailed Analysis & Overview
Hear from Dr. Andrew Byrnes during the third installment of the BIO-ASGCT CGT Science Series. In this keynote from the 2023 CGT Summit hosted by Charles River Laboratories, Dr. Peter Marks, Director of the FDA's Center for ... Advancing RNA Live panelists Venkat Krishnamurthy, April Sena, and Max De Long share their perspectives on the most ... In this episode of the DES Pharma Podcast, we sit down to unpack the FDA's January 11th ... This presentation highlighted key clinical regulatory issues encountered during early-phase development of This presentation addressed CBER's Chemistry, Manufacturing, and Control considerations for early phase studies of
In this in-depth keynote from the 2024 CGT Summit hosted by Charles River Laboratories, Dr. Peter Marks, Director of the FDA's ... Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA) Learn why regulatory and chemistry, manufacturing and controls ( In this BioProcess Buzz episode from BioProcess International Week in Boston, Alvin sits down with Rene from LumaCyte. September 26, 2025 Yale's Review of Advances in Oncology from the 2025 ASCO Annual Meeting Presenters: Michael Hurwitz, ...
